Clinical trials
Phase 4 Community-Acquired Pneumonia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2012 | 5 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Unknown status | 9 |
| Recruiting | 4 |
| Terminated | 3 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 1 |
| Beijing Hospital | 1 |
| China Academy of Chinese Medical Sciences | 1 |
| Copenhagen Respiratory Research | 1 |
| David Garcia Cinca | 1 |
| Dr. Md. Alimur Reza | 1 |
| Federal University of Bahia | 1 |
| Forest Laboratories | 1 |
| Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana | 1 |
| Future University in Egypt | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Community-Acquired Pneumonia | 35 |
| Pneumonia | 9 |
| Pneumonia, Bacterial | 3 |
| Healthcare-Associated Pneumonia | 2 |
| Asthma | 1 |
| Bacterial Infections | 1 |
| Bronchopneumonia | 1 |
| Coccidioidomycosis | 1 |
| Community-Acquired Infections | 1 |
| Critical Illness | 1 |
Trials
Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.